The REAL-PE analysis is the largest real-world and near real-time dataset evaluating advanced therapies for PE patients.
The results? Patients treated with the EKOS system had statistically significant lower rates of major bleeding and intracerebral hemorrhage than patients treated with Inari Medical’s™ FlowTriever™ system. In fact, all studied safety events trended in favor of the EKOS system, as did 30-day all-cause readmission rates.1
Hear from lead author Peter Monteleone, MD, as he discusses the REAL-PE analysis
In comparison to patients who were treated with the FlowTriever System, patients treated with the EKOS system had a statistically significant:
28%
lower rate of major bleeding events*1
FlowTriever (n=118/682),
EKOS (n=195/1577), p=0.0018
(ISTH Definition)
77%
lower rate of intracerebral hemorrhage (0.3% incidence of ICH in patients treated with EKOS)*1
FlowTriever (n=9/682), EKOS (n=5/1577), p=0.005
Comparable in-hospital mortality rates (p=0.167), 30-day all-cause readmission rates (p=0.777), and median lengths of hospital stay*1